Results 211 to 220 of about 496,613 (305)

Potential vulnerability of US green hydrogen in a world of interdependent networks. [PDF]

iScience
Pourshahabi S, Shutters ST, Muneepeerakul R, Altiparmak SO.   +3 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

The Intermediary Metabolism of Pyrene [PDF]

British Journal of Cancer, 1958
openaire   +2 more sources

Interoperability architecture for data spaces. [PDF]

Data Brief
Soininen JP, Sánchez CF, Modafferi S, Campbell S, Tomas N, Salant E, Manara C, Kalaoja J, Datta SK.   +8 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Intermediary metabolism of mycobacteria

Bacteriological Reviews, 1972
T, Ramakrishnan, P S, Murthy, K P, Gopinathan   +2 more
openaire   +2 more sources

The responsibilities of a commercial intermediation company as a new food business: the case of a typical regional Italian food. [PDF]

J Prev Med Hyg
Trucchi C, Roveta M, Baldoni E, Romairone F, Piccinini C, Schinca E, Sartini M, Cristina ML.   +7 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Effects of endocrine disrupting chemicals and plasma metabolome on female reproductive diseases: A multidimensional Mendelian randomization study. [PDF]

Medicine (Baltimore)
Yin B, Li C, Pei Y, Wei H, Liang L, Zhu C, Song C.   +6 more
europepmc   +1 more source